P & G Profit Up 20% on Acquisition, Drug Sales
- Share via
From Bloomberg News
Procter & Gamble Co. said first-quarter profit increased 20% as beauty-care acquisitions and a new Prilosec heartburn drug boosted sales by the most in eight years.
Net income rose to $1.76 billion, or $1.26 a share, from $1.46 billion, or $1.04, a year earlier, the Cincinnati-based company said. Sales in the quarter ended Sept. 30 rose 13% to $12.2 billion, bolstered 3 percentage points by a weakening dollar.
Procter & Gamble shares rose 74 cents to $96.80 on the NYSE.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
